Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:50:40 +0200Tue, 14 May 2024 16:25:00 +0200Human medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/thalidomide-lipomedHuman medicines European public assessment report (EPAR): Thalidomide Lipomed, thalidomide, Date of authorisation: 19/09/2022, Revision: 1, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/thalidomide-lipomedTue, 14 May 2024 16:25:00 +0200Human medicineThalidomide Lipomed : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5715_en_1.pdfThalidomide Lipomed : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5715_en_1.pdfTue, 14 May 2024 13:30:00 +0200Human medicine